Sonoma Pharmaceuticals (SNOA) Net Cash Flow (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Net Cash Flow of -$161000.0 for Q1 2026, down 261.0% year-over-year from $100000.0 in Q1 2025, and up 73.21% quarter-over-quarter from -$601000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Net Cash Flow (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$161000.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 261.0% year-over-year to -$161000.0; the TTM figure through Mar 2026 stood at -$3.6 million (down 227.46% YoY), while the FY2026 annual figure was -$3.6 million, down 227.46% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$161000.0, up from -$601000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $1.8 million in Q3 2024, with the low at -$2.2 million in Q3 2022.
- The 5-year median for Net Cash Flow is -$367000.0 (2023), against an average of -$392058.8.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow jumped 496.71% in 2024, then slumped 675.44% in 2025.
- Sonoma Pharmaceuticals' Net Cash Flow stood at -$632000.0 in 2022, then soared by 133.7% to $213000.0 in 2023, then surged by 496.71% to $1.3 million in 2024, then plunged by 147.29% to -$601000.0 in 2025, then soared by 73.21% to -$161000.0 in 2026.
- Business Quant data shows SNOA's Net Cash Flow at -$161000.0 in Q1 2026, -$601000.0 in Q4 2025, and -$707000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.80 Mn |
| Jun 30, 2026 | 2.80 Mn |
| Mar 31, 2026 | -161,000.00 |
| Mar 31, 2026 | -161,000.00 |
| Dec 31, 2025 | -601,000.00 |
| Dec 31, 2025 | -601,000.00 |
| Sep 30, 2025 | -707,000.00 |
| Sep 30, 2025 | -707,000.00 |
| Jun 30, 2025 | -2.18 Mn |
| Jun 30, 2025 | -2.18 Mn |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | -281,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | 792,000.00 |
| Mar 31, 2024 | 792,000.00 |